U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik June 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Edgewise Therapeutics, IBM and Rubrik, on Tuesday.
HIGHLIGHTS
* Edgewise Therapeutics Inc EWTX.O: Raymond James raises target price to $66 from $52 |
* IBM IBM.N: Wedbsuh raises target price to $350 from $320 |
* Praxis Precision Medicines Inc PRAX.O: Baird cuts target price to $400 from $433 |
* Rubrik Inc RBRK.N: Jefferies raises target price to $100 from $65 |
* Vulcan Materials Co VMC.N: Berenberg initiates coverage with hold rating; PT $283 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Aktis Oncology Inc AKTS.O: H.C. Wainwright raises target price to $35 from $33 |
* Allegiant Travel Company ALGT.O: BofA Global Research raises PO to $100 from $90 |
* Alphabet Inc GOOGL.O: HSBC cuts target price to $420 from $435 |
* Ares Commercial Real Estate Corp ACRE.N: UBS raises target price to $5.5 from $5 |
* Arxis Inc ARXS.O: Citigroup raises target price to $50 from $42 |
* Blackstone Mortgage Trust Inc BXMT.N: UBS raises target price to $21 from $20 |
* Blackstone Mortgage Trust Inc BXMT.N: UBS raises to buy from neutral |
* BorgWarner Inc. BWA.N: Wells Fargo raises target price to $83 from $68 |
* Brightspring Health Services BTSG.O: Morgan Stanley raises PT to $71.00 from $62.00 |
* Bruker Corporation BRKR.O: BofA Global Research raises price objective to $65 from $49 |
* Caesars Entertainment Inc CZR.O: Macquarie cuts target price to $31 from $35 |
* Caesars Entertainment Inc CZR.O: Macquarie cuts to neutral from outperform |
* Caesars Entertainment Inc CZR.O: Wells Fargo raises target price to $31 from $26 |
* Campbell's Co CPB.O: UBS cuts target price to $19 from $20 |
* Chewy Inc CHWY.N: JP Morgan cuts target price to $35 from $40 |
* Ciena Corp CIEN.N: B. Riley raises target price to $531 from $283 |
* Conagra Brands Inc CAG.N: UBS cuts target price to $13 from $16 |
* Constellation Energy Corp CEG.O: Raymond James cuts target price to $374 from $392 |
* Edgewise Therapeutics Inc EWTX.O: Raymond James raises target price to $66 from $52 |
* Edwards Lifesciences Corp EW.N: TD Cowen raises target price to $104 from $97 |
* Enliven Therapeutics Inc ELVN.O: Mizuho raises target price to $62 from $45 |
* Fedex FDX.N: BMO cuts target price to $340 from $410 |
* Fedex Corp. FDX.N: BofA Global Research cuts price objective to $376.00 from $440.00 |
* Fedex Freight Holding Co FDXF.N: Truist Securities initiates coverage with hold rating |
* Fedex Freight Holding Co FDXF.N: Truist Securities initiates coverage with PT $155 |
* Five Below FIVE.O: Deutsche Bank raises target price to $298 from $287 |
* Fulcrum Therapeutics FULC.O: H.C. Wainwright cuts target price to $3 from $25 |
* Fulcrum Therapeutics FULC.O: Leerink Partners cuts PT to $4 from $24 |
* Fulcrum Therapeutics FULC.O: Leerink Partners cuts to market perform from outperform |
* Fulcrum Therapeutics FULC.O: Piper Sandler cuts target price to $3 from $23 |
* Fulcrum Therapeutics FULC.O: Piper Sandler cuts to underweight from overweight |
* Fulcrum Therapeutics FULC.O: Stifel cuts to hold from buy; cuts PT to $3 from $25 |
* Fulcrum Therapeutics Inc FULC.O: H.C. Wainwright cuts to neutral from buy |
* Fulcrum Therapeutics Inc FULC.O: Truist Securities cuts target price to $4 from $17 |
* Fulcrum Therapeutics Inc FULC.O: Truist Securities cuts to hold from buy |
* General Mills Inc GIS.N: UBS cuts target price to $30 from $35 |
* Guardant Health Inc GH.O: Evercore ISI raises PT to $160 from $95 |
* Guardant Health Inc GH.O: Evercore ISI raises to outperform from in line |
* Hewlett Packard Enterprise HPE.N: Morgan Stanley raises PT to $71 from $33 |
* Hewlett Packard Enterprise Co HPE.N: Bernstein raises target price to $62 from $35 |
* Hewlett Packard Enterprise Co HPE.N: BofA Global Research raises PO to $80 from $38 |
* Hewlett Packard Enterprise Co HPE.N: Citigroup raises target price to $70 from $39 |
* Hewlett Packard Enterprise Co HPE.N: Evercore ISI raises target price to $70 from $40 |
* Hewlett Packard Enterprise Co HPE.N: JP Morgan raises target price to $68 from $37 |
* Hewlett Packard Enterprise Co HPE.N: Morgan Stanley raises PT to $71 from $33 |
* Hewlett Packard Enterprise Co HPE.N: Piper Sandler raises target price to $63 from $23 |
* Hewlett Packard Enterprise Co HPE.N: Susquehanna raises target price to $65 from $21 |
* Hewlett Packard Enterprise Co HPE.N: Truist Securities raises PT to $69 from $31 |
* Hewlett Packard Enterprise Co HPE.N: UBS raises target price to $65 from $25 |
* Hewlett Packard Enterprise Company HPE.N: Wells Fargo raises PT to $67 from $26 |
* Host Hotels and Resorts, Inc HST.O: UBS raises target price to $23 from $20 |
* IBM IBM.N: Wedbsuh raises target price to $350 from $320 |
* Idex Corporation IEX.N: Oppenheimer raises target price to $250 from $242 |
* Intuitive Surgical ISRG.O: Deutsche Bank cuts target price to $366 from $440 |
* J.M. Smucker Co SJM.N: UBS cuts target price to $121 from $132 |
* Life Time Group Holdings Inc LTH.N: RBC raises target price to $43 from $38 |
* Lineage Inc LINE.O: Morgan Stanley raises target price to $47 from $39 |
* Macerich Co MAC.N: Deutsche Bank raises to buy from hold; raises PT to $27 from $20 |
* Macerich Company MAC.N: Deutsche Bank raises target price to $27 from $20 |
* Macerich Company MAC.N: Deutsche Bank raises to buy from hold |
* Maplight Therapeutics Inc MPLT.O: Stifel raises target price to $36 from $28 |
* Martin Marietta Materials Inc MLM.N: Berenberg initiates coverage with hold rating |
* Martin Marietta Materials Inc MLM.N: Berenberg initiates coverage with PT $556 |
* McCormick & Company Inc MKC.N: UBS cuts target price to $51 from $53 |
* MGM Resorts International MGM.N: Deutsche Bank raises target price to $55 from $48 |
* Mirum Pharmaceuticals Inc MIRM.O: Citigroup initiates coverage with buy rating; PT $145 |
* Mobia Medical Inc MOBI.O: BofA Global Research initiates coverage with buy rating |
* Mobia Medical Inc MOBI.O: BofA Global Research initiates coverage with PO $16.00 |
* Mobia Medical Inc MOBI.O: BTIG initiates coverage with buy rating; price target $19 |
* Mobia Medical Inc MOBI.O: JP Morgan initiates coverage with overweight rating; PT $15 |
* Navan Inc NAVN.O: TD Cowen raises target price to $28 from $19 |
* Octave Intelligence Plc OCTV.O: RBC initiates coverage with sector perform rating |
* Octave Intelligence Plc OCTV.O: RBC initiates coverage with target price $21 |
* Odyssey Therapeutics Inc ODTX.O: TD Cowen initiates coverage with buy rating |
* Odyssey Therapeutics Inc ODTX.O: Wedbush initiates coverage with outperform rating; PT $30 |
* Oracle Corp ORCL.N: Scotiabank raises target price to $290 from $215 |
* Oracle Corp ORCL.N: UBS raises target price to $285 from $250 |
* Oxford Industries Inc OXM.N: UBS raises target price to $42 from $33 |
* Penguin Solutions Inc PENG.O: Rosenblatt Securities raises PT to $65 from $54 |
* Penguin Solutions Inc PENG.O: Stifel raises target price to $66 from $24 |
* Praxis Precision Medicines Inc PRAX.O: Baird cuts target price to $400 from $433 |
* Praxis Precision Medicines Inc PRAX.O: Raymond James cuts PT to $765 from $815 |
* Praxis Precision Medicines Inc PRAX.O: TD Cowen cuts target price to $510 from $554 |
* Praxis Precision Medicines Inc PRAX.O: Truist Securities cuts PT to $616 from $715 |
* Praxis Precision Medicines, Inc. PRAX.O: Deutsche Bank cuts PT to $374 from $420 |
* Praxis Precision Medicines, Inc. PRAX.O: H.C. Wainwright cuts PT to $1,201 from $1,245 |
* Progyny PGNY.O: BofA Global Research raises price objective to $31.00 from $29.00 |
* Revolution Medicines Inc RVMD.O: RBC raises target price to $182 from $165 |
* Rubrik Inc RBRK.N: Jefferies raises target price to $100 from $65 |
* Sable Offshore Corp SOC.N: Gerdes Energy Research cuts target price by $4 to $13 |
* Sable Offshore Corp SOC.N: Gerdes Energy Research cuts to neutral from buy |
* Sailpoint Inc SAIL.O: Barclays raises target price to $22 from $16 |
* Science Applications International SAIC.O: Truist Securities raises PT to $110 from $95 |
* Science Applications International Corp SAIC.O: JP Morgan raises PT to $125 from $110 |
* Seven Hills Realty Trust SEVN.O: UBS initiates coverage with buy rating and PT $10 |
* Sezzle Inc SEZL.O: B. Riley raises target price to $141 from $117 |
* Sherwin-Williams Co SHW.N: UBS cuts target price to $330 from $385 |
* Sherwin-Williams Co SHW.N: UBS cuts to neutral from buy |
* Simply Good Foods Co SMPL.O: UBS cuts target price to $12 from $13 |
* Standardaero Inc SARO.N: Jefferies cuts target price to $30 from $34 |
* Standardaero Inc SARO.N: Jefferies cuts to hold from buy |
* Starwood Property Trust Inc (Maryland) STWD.N: UBS raises PT to $20 from $19.5 |
* Starwood Property Trust Inc (Maryland) STWD.N: UBS raises to buy from neutral |
* Strive Inc ASST.O: Benchmark initiates coverage with buy rating; target price $32 |
* Take-Two Interactive Software TTWO.O: Piper Sandler initiates coverage with overweight rating |
* Take-Two Interactive Software TTWO.O: Piper Sandler initiates coverage with PT $280 |
* Taylor Morrison Home Corp TMHC.N: RBC cuts to sector perform from outperform |
* Taylor Morrison Home Corp TMHC.N: Truist Securities cuts to hold from buy |
* Unity Software Inc U.N: Piper Sandler raises target price to $40 from $35 |
* Veradermics Inc MANE.N: Needham initiates coverage with buy rating; PT $136 |
* Visteon Corp VC.O: Wells Fargo raises target price to $139 from $125 |
* Vulcan Materials Co VMC.N: Berenberg initiates coverage with hold rating; PT $283 |
* Waters Corp WAT.N: BofA Global Research raises price objective to $400 from $370 |
* Western Digital Corp WDC.O: Citigroup raises target price to $685 from $500 |
* X4 Pharmaceuticals XFOR.O: Leerink Partners initiates coverage with outperform rating |
* X4 Pharmaceuticals XFOR.O: Leerink Partners initiates coverage with price target $12 |
* Zoom Communications Inc ZM.O: HSBC raises target price to $133 from $107 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Martin Marietta Materials
See all newsU.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
U.S. RESEARCH ROUNDUP- Alphabet, Colgate-Palmolive, Welltower
Martin Marietta Materials profit rises on strong pricing, infrastructure demand
Martin Marietta Q1 revenue rises 17%, beats estimates; backs FY forecast
U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler